Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure

RegulatoryNegative

AI Analysis

Summary

U.S. tariffs on imported patented medicines and their ingredients expanded on September 29, 2026, to affect mid-sized and smaller drugmakers, following initial duties imposed on 17 large manufacturers on July 31. The industry has warned of potential R&D pressure from these tariff expansions.

Outcome Details

U.S. tariffs on imported patented medicines and ingredients expanded to mid-sized and smaller drugmakers effective September 29, 2026

Importance:5/10

Sentiment:

-0.70

tariffsregulatorypharma policyR&D pressuretrade

Related Companies

$NHPAP $TRAX

Read the original article

Published by Drug Discovery & Development on September 29, 2026 4:42 PM

Read Original